CEO Matthew Weinberg Presents at FDA Clinical Trials Hearing
April 23, 2012
April 23 - The Weinberg Group CEO, Matthew Weinberg, presented today at FDA’s hearing titled “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice.” Mr. Weinberg presented on the mandatory need for audits and audit independence. A full copy of his presentation can be found below.
For more information on The Weinberg Group’s independent clinical auditing services, please contact Jeff Antos, Vice President, at email@example.com or 202.280.0815.
Subscribe for Updates
April 17, 2018
The Weinberg Group CEO to Speak at AIPPI’s International Convention on the Economy of Innovation
WASHINGTON, DC – April 17, 2018 – Matthew Weinberg, Chief Executive Officer of The Weinberg Group Inc., will be speaking at the International Association for the Protection of Intellectual Property’s...